Literature DB >> 25748951

Evaluation of myocardial triglyceride accumulation assessed on 1H-magnetic resonance spectroscopy in apparently healthy Japanese subjects.

Eiryu Sai1, Kazunori Shimada, Takayuki Yokoyama, Shuji Sato, Yuji Nishizaki, Tetsuro Miyazaki, Makoto Hiki, Yoshifumi Tamura, Shigeki Aoki, Hirotaka Watada, Ryuzo Kawamori, Hiroyuki Daida.   

Abstract

OBJECTIVE: Proton magnetic resonance spectroscopy ((1)H-MRS) enables the clinician to noninvasively assess the amount of ectopic fat in the liver, skeletal muscle and myocardium. Recent studies have reported that the myocardial triglyceride (TG) content is associated with aging, metabolic disorders and cardiac dysfunction. However, the clinical usefulness of myocardial TG measurements in Japanese subjects has not been fully investigated.
METHODS: The myocardial TG content was evaluated using (1)H-MRS in 37 apparently healthy Japanese subjects, and the left ventricular function was measured on cardiac magnetic resonance imaging (MRI). Blood pressure, body composition and biochemical markers were measured in a fasting state, and cardiopulmonary exercise testing (CPX) was performed to evaluate exercise capacity.
RESULTS: The mean myocardial TG content was 0.85±0.40%. The myocardial TG content was significantly associated with the percent body fat (r=0.39), serum triglyceride level (r=0.40), estimated glomerular filtration rate (r=-0.37), anaerobic threshold (r=-0.36), maximal load of CPX (r=0.39), left ventricular end-diastolic volume (r=-0.41) and left ventricular end-systolic volume (LVESV) (r=-0.51) (all: p<0.05). In a multivariate analysis, the LVESV was found to be an independent factor of the myocardial TG content.
CONCLUSION: (1)H-MRS may be useful for assessing the associations between the myocardial TG content and various clinical parameters, including those reflecting obesity, metabolic disorders, cardiac morphology and exercise capacity, noninvasively, even in Japanese subjects.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25748951     DOI: 10.2169/internalmedicine.54.3024

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  1H- and 31P-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes.

Authors:  Francesco Secchi; Giovanni Di Leo; Marcello Petrini; Riccardo Spairani; Marco Alì; Marco Guazzi; Francesco Sardanelli
Journal:  Radiol Med       Date:  2017-01-09       Impact factor: 3.469

2.  Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy.

Authors:  Eiryu Sai; Kazunori Shimada; Takayuki Yokoyama; Makoto Hiki; Shuji Sato; Nozomi Hamasaki; Masaki Maruyama; Ryoko Morimoto; Tetsuro Miyazaki; Shinichiro Fujimoto; Yoshifumi Tamura; Shigeki Aoki; Hirotaka Watada; Ryuzo Kawamori; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2016-05-03       Impact factor: 2.037

3.  Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin's Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes.

Authors:  Fumika Shigiyama; Shigenori Hiruma; Shinji Hisatake; Nobuyuki Shiraga; Takanori Ikeda; Takahisa Hirose; Naoki Kumashiro
Journal:  Diabetes Ther       Date:  2019-06-06       Impact factor: 2.945

4.  A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.

Authors:  Shigenori Hiruma; Fumika Shigiyama; Shinji Hisatake; Sunao Mizumura; Nobuyuki Shiraga; Masaaki Hori; Takanori Ikeda; Takahisa Hirose; Naoki Kumashiro
Journal:  Cardiovasc Diabetol       Date:  2021-02-02       Impact factor: 9.951

5.  Triglyceride Deposit Cardiomyovasculopathy with Massive Myocardial Triglyceride which Was Proven Using Proton-magnetic Resonance Spectroscopy.

Authors:  Eiryu Sai; Kazunori Shimada; Tatsuro Aikawa; Chihiro Aoshima; Kazuhisa Takamura; Makoto Hiki; Takayuki Yokoyama; Tetsuro Miyazaki; Shinichiro Fujmoto; Hakuoh Konishi; Ken-Ichi Hirano; Hiroyuki Daida; Tohru Minamino
Journal:  Intern Med       Date:  2020-11-09       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.